Viewing Study NCT02423057

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 6:37 PM
Ignite Modification Date: 2026-02-22 @ 7:23 PM
Study NCT ID: NCT02423057
Status: COMPLETED
Last Update Posted: 2025-09-30
First Post: 2015-04-18
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Phase I Trial of 4'-Thio-2'-Deoxycytidine (TdCyd) in Patients With Advanced Solid Tumors
Sponsor: National Cancer Institute (NCI)
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Neoplasms View
None Solid Tumors View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Pharmacodynamics View
None DNA Methylation View
None Pharmacokinetics View
None Nucleoside Analog View
None Epigenetics View